Inter-fraction robustness of intensity-modulated proton therapy in the post-operative treatment of oropharyngeal and oral cavity squamous cell carcinomas.


Journal

The British journal of radiology
ISSN: 1748-880X
Titre abrégé: Br J Radiol
Pays: England
ID NLM: 0373125

Informations de publication

Date de publication:
Mar 2020
Historique:
pubmed: 18 12 2019
medline: 28 2 2020
entrez: 18 12 2019
Statut: ppublish

Résumé

To evaluate dosimetric consequences of inter-fraction setup variation and anatomical changes in patients receiving multifield optimised (MFO) intensity modulated proton therapy for post-operative oropharyngeal (OPC) and oral cavity (OCC) cancers. Six patients receiving MFO for post-operative OPC and OCC were evaluated. Plans were robustly optimised to clinical target volumes (CTVs) using 3 mm setup and 3.5% range uncertainty. Weekly online cone beam CT (CBCT) were performed. Planning CT was deformed to the CBCT to create virtual CTs (vCTs) on which the planned dose was recalculated. vCT plan robustness was evaluated using a setup uncertainty of 1.5 mm and range uncertainty of 3.5%. Target coverage, D Robustly optimised plans in post-operative OPC and OCC patients are robust against inter-fraction setup variations and range uncertainty. D MFO plans in post-operative OPC and OCC patients are robust to inter-fraction uncertainties in setup and range when evaluated over multiple CT scans without compromising OAR mean dose. This is the first paper to evaluate inter-fraction MFO plan robustness in post-operative head and neck treatment.

Identifiants

pubmed: 31845816
doi: 10.1259/bjr.20190638
pmc: PMC7066971
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20190638

Subventions

Organisme : Medical Research Council
ID : MC_U137686858
Pays : United Kingdom

Références

Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):738-749
pubmed: 29280468
Med Phys. 2013 May;40(5):051711
pubmed: 23635259
Phys Med Biol. 2015 Apr 7;60(7):2671-84
pubmed: 25768095
Radiother Oncol. 2019 Feb;131:127-134
pubmed: 30773179
Med Phys. 2011 Mar;38(3):1672-84
pubmed: 21520880
Radiother Oncol. 2016 May;119(2):221-8
pubmed: 27178143
Nutr Cancer. 2013;65(1):76-83
pubmed: 23368916
Radiother Oncol. 2020 Jan;142:124-132
pubmed: 31564553
Phys Med Biol. 2008 Feb 21;53(4):1043-56
pubmed: 18263957
Med Phys. 2015 Aug;42(8):4840-7
pubmed: 26233211
Br J Radiol. 2013 Jan;86(1021):20120288
pubmed: 23255545
Med Phys. 2012 Feb;39(2):1079-91
pubmed: 22320818
Phys Med Biol. 1996 Jan;41(1):111-24
pubmed: 8685250
Phys Med Biol. 2007 Feb 7;52(3):635-44
pubmed: 17228110
Phys Med Biol. 2007 May 21;52(10):2755-73
pubmed: 17473350

Auteurs

Christina Hague (C)

Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK.

Marianne Aznar (M)

Manchester Cancer Research Centre, Division of Molecularand Clinical Cancer Science, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic HealthSciences Centre, Manchester, UK.
The Christie NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK.

Lei Dong (L)

Department of Radiation Oncology, University of Pennsylvania, Philadelphia, USA.

Alireza Fotouhi-Ghiam (A)

Department of Radiation Oncology, University of Pennsylvania, Philadelphia, USA.

Lip Wai Lee (LW)

Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.

Taoran Li (T)

Department of Radiation Oncology, University of Pennsylvania, Philadelphia, USA.

Alexander Lin (A)

Department of Radiation Oncology, University of Pennsylvania, Philadelphia, USA.

Matthew Lowe (M)

Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK.

John N Lukens (JN)

Department of Radiation Oncology, University of Pennsylvania, Philadelphia, USA.

Andrew McPartlin (A)

Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.

Shannon O'Reilly (S)

Department of Radiation Oncology, University of Pennsylvania, Philadelphia, USA.

Nick Slevin (N)

Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK.

Samuel Swisher-Mcclure (S)

Department of Radiation Oncology, University of Pennsylvania, Philadelphia, USA.

David Thomson (D)

Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK.

Marcel Van Herk (M)

Division Clinical Cancer Science, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Department of Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, UK.

Catharine West (C)

Translational Radiobiology Group, Division of Cancer Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.
The Christie NHS Foundation Trust, Manchester, UK.

Wei Zou (W)

Department of Radiation Oncology, University of Pennsylvania, Philadelphia, USA.

Boon-Keng Kevin Teo (BK)

Department of Radiation Oncology, University of Pennsylvania, Philadelphia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH